In a recently published study, Finnish researcher Jari Tiihonen and colleagues have concluded, based on their examination of a prescription data base, that first-episode schizophrenia patients who take antipsychotics continuously have lower mortality rates and lower risk of being rehospitalized than those who discontinue the drugs. Joanna Moncrieff and Sandy Steingard investigate the findings.
by Sandra Steingard, MD
by Joanna Moncrieff, MD
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.